Mortality rate of bullous pemphigoid in a US Medical Center

Journal of Investigative Dermatology

Volumn 122, Issue 5, 2004, Pages 1091-1095

  Colbert, Rand L ^a   Allen, David M ^a   Eastwood, Daniel ^a   Fairley, Janet A ^a,b  

^a CLEMENT J ZABLOCKI VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b Department of Dermatology ^*  (United States)

Author keywords

Autoimmunity; Bullous pemphigoid; Mortality

Indexed keywords

AZATHIOPRINE; CYCLOPHOSPHAMIDE; DAPSONE; IMMUNOGLOBULIN; IMMUNOSUPPRESSIVE AGENT; MYCOPHENOLIC ACID; NICOTINAMIDE; PREDNISONE; STEROID; TETRACYCLINE;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; COMORBIDITY; CONTROLLED STUDY; FEMALE; FOLLOW UP; GEOGRAPHIC PATHOLOGY; HOSPITAL; HOSPITALIZATION; HUMAN; KAPLAN MEIER METHOD; MALE; MORBIDITY; MORTALITY; ONSET AGE; PATIENT INFORMATION; PEMPHIGOID; PRIORITY JOURNAL; SURVIVAL RATE; TIME OF DEATH; TREATMENT INDICATION;

EID: 2442606250     PISSN: 0022202X     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.0022-202X.2004.22504.x     Document Type: Article

References (22)

1. Ahmed AR: Intravenous immunoglobulin therapy for patients with bullous pemphigoid unresponsive to conventional immunosuppressive treatment. J Am Acad Dermatol 45:825-835, 2001
2. Ahmed AR, Maize JC, Provost TT: Bullous pemphigoid. Clinical and immunologic follow-up after successful therapy. Arch Dermatol 113:1043-1046, 1977
3. Angus D, Linde-Zwirble W, Lidicker J, Clermont G, Carcillo J, Pinsky M: Epidemiology of severe sepsis in the United States: Analysis of incidence, outcome, and associated costs of care. Crit Care Med 29:1303-1310, 2001
4. Arias E, Smith BL: Deaths: Preliminary data for 2001. Natl Vital Stat Rep 51:1-45, 2003
5. Bernard P, Bedane C, Bonnetblanc JM: Anti-BP180 autoantibodies as a marker of poor prognosis in bullous pemphigoid: A cohort analysis of 94 elderly patients. Br J Dermatol 136:694-698, 1997
6. Bernard P, Enginger V, Venot J, Bedane C, Bonnetblane JM: Survival prognosis in pemphigoid: A cohort analysis of 78 patients. Ann Dermatol Venereol 122:751-757, 1995
7. Brun-Buisson C, Doyon F, Carlet J: Bacteremia and severe sepsis in adults: A multicenter prospective survey in ICUs and wards of 24 hospitals. Am J Respir Crit Care Med 154:617-624, 1996
8. Dimson OG, Giudice GJ, Fu C-L, Warren SJ, Janson MM, Fairley JA: Identification of a potential effector function for IgE autoantibodies in the organ-specific autoimmune disease bullous pemphigoid. J Invest Dermatol 120:784-788, 2003
9. Fivenson DP, Breneman DL, Rosen GB, Hersh CS, Cardone S, Mutasim D: Nicotinamide and tetracycline therapy of bullous pemphigoid. Arch Dermatol 130:753-758, 1994
10. Joly P, Roujeau JC, Benichou J, et al: A comparison of oral and topical corticosteroids in patients with bullous pemphigoid. N Engl J Med 346:321-327, 2002
11. Jordon RE, Beutner EH, Witebsky E, Blumenthal G, Hale WC, Lever WF: Basement zone antibodies in bullous pemphigoid. J Am Med Assoc 200:751-758, 1967
12. Jung M, Kippes W, Messer G, Zillikens D, Rzany B: Increased risk of bullous pemphigoid in male and very old patients: A population-based study on incidence. J Am Acad Dermatol 41:266-268, 1999
13. Labib RS, Anhalt GJ, Patel HP, et al: Molecular heterogeneity of bullous pemphigoid antigens as detected by immunoblotting. J Immunol 136:1231-1235, 1986
14. Liu Z, Diaz LA, Troy JL, Taylor AF, Emery DJ, Fairley JA, Giudice GJ: A passive transfer model of the organ-specific autoimmune disease, bullous pemphigoid, using antibodies generated against the hemidesmosomal antigen, BP180. J Clin Invest 92:2480-2468, 1993
15. Korman NJ: Bullous pemphigoid: The latest in diagnosis, prognosis, and therapy. Arch Dermatol 134:1137-1141, 1998
16. Munford RS: Sepsis and Septic Shock. Harrison's Principles of Internal Medicine, 15. New York: McGraw-Hill, 2001
17. Roujeau J-C, Lok C, Bastuji-Garin S, Mhalla S, Enginger V, Bernard P: High risk of death in elderly patients with extensive bullous pemphigoid. Arch Dermatol 134:465-469, 1998
18. Rzany B, Partscht K, Jung M, et al: Risk factors for lethal outcome in patients with bullous pemphigoid. Arch Dermatol 138:903-908, 2002
19. Sands KE, Bates DW, Lanken PN: Epidemiology of sepsis syndrome in 8 academic medical centers. JAMA 278:234-240, 1997
20. Sonnenblick M, Carmon M, Rudenski B, Friedlander Y, Van Dijk JM: Septicemia in the elderly: Incidence, etiology and prognostic factors. Isr J Med Sci 26:195-199, 1990
21. Stanley JR, Hawley-Nelson P, Yuspa SH, et al: Characterization of bullous pemphigoid antigen: A unique basement membrane protein of stratified squamous epithelia. Cell 24:897-903, 1981
22. Venning VA, Wojnarowska F: Lack of predictive factors for the clinical course of bullous pemphigoid. J Am Acad Dermatol 26:585-589, 1992